진원생명과학
2,670KRWMarket close of 10/28 (Wed)
No trade that dayMarket close of 10/28 (Wed)
- Volume
- 0×10K shares
- 0 KRW
Open, high and low are not shown — the source has no bar for the reference date
Market close of 10/28 (Wed)
Where it sits in the 1-year range
0%0% of the way up from the lowest close in 1 year (252 sessions) · -80.9% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto checkNo trades this day (0 shares)
- Earningsto check-37.3B KRWOperating income over the last four quarters -37.3B KRW (loss)
- Trading valuenot verifiedNo trading that day, so not compared with usual trading value
The other 2
- Recent filingsnot verified
- Foreign & institutionalnot verified
See the full check report
Quarterly results · Q1 2026
- Revenue2.6B KRW
- vs. year ago
- -69.6%
- vs. prior quarter
- -2.7%
- Operating income-2.3B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-90.8%
- vs. year ago
- +15.8 pp
- vs. prior quarter
- +404.1 pp
Quarterly operating income trend
As of the latest official close · 2026-10-28Valuation filing date · 2026-05-15Same sector · 제약
Up +0.44%· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +6.1% | Up +0.64% | 80.0B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -0.9% | Down -0.15% | 68.9B KRW |
| 파마리서치 | Close over the last 20 sessions -27.8% | Down -1.30% | 43.9B KRW |
| 한미약품 | Close over the last 20 sessions -27.1% | Up +5.42% | 42.3B KRW |
| 삼익제약 | Close over the last 20 sessions -13.1% | Up +9.54% | 34.5B KRW |
Schedule
- Next data 10/30 (Fri) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.